AMD: Analysts Call For Q2 Revenues Of $6.55 Billion

Advanced Micro Devices (NASDAQ: AMD) will be reporting its second quarter financial results today after market close. Analysts have a consensus $128.11 12-month price target on the company, via a total of 42 analysts, with nine analysts having strong buy ratings.

19 analysts meanwhile have buy ratings, 13 analysts have hold ratings and a single analyst has a sell rating on the stock. The street high comes from Elazar Advisors with a $230 price target, and the lowest target sits at $85.

26 analysts have revenue estimates for the second quarter. The mean revenue estimate between all 26 analysts is $6.55 billion; this number has been revised upwards since the start of the year. The highest revenue estimate is $6.7 billion, while the lowest is $6.5 billion.

Onto EBITDA estimates, there are currently only 4 analysts who have second-quarter EBITDA estimates. The mean is currently $2.1 billion. The estimate has been revised lower since the start of the year. Street high is a $2.1 billion EBITDA estimate, and the lowest is $2 billion.

Analysts estimate that quarterly earnings per share will come in at $1.03, up from the $0.78 estimate at the start of the year. The street high estimate is $1.16, and the lowest estimate is $0.97 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

8 Mining Stocks Our Viewers Asked Us to Review | Sept 14th-18th

Canada Is Finally Fast-Tracking New Mines | John Passalacqua – First Phosphate

Gold & Silver Just Added $2 Billion to This Project | Aya Gold – Bourmadine PEA

Recommended

Mercado Minerals Signs LOI for La Franca, Adding 750 Metres of Undrilled Vein at Zamora

Goliath Hits Visible Gold In Bonanza Zone Step-Outs, Drills 9.12 g/t Gold Equivalent Over 11.27 Metres

Related News

Medipharm Labs: Canaccord Drops Target To Just $0.10

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company...

Tuesday, May 24, 2022, 11:37:00 AM

Xebec: Canaccord Views Three Year Plan As Ambitious, Without Risk

After an uneventful and lackluster quarter, Xebec Adsorption (TSX: XBC) provided investors with a three-year...

Friday, April 1, 2022, 03:43:00 PM

CareRx: Canaccord Raises Price Target To $6.50 Following Financing

Earlier this week, CareRx Corp (TSX: CRRX) closed their C$21.2 million bought deal. Notably, $6.25...

Friday, February 5, 2021, 11:45:00 AM

FuboTV Gets Downgraded To Market Perform By BMO Capital Markets, Stock Falls

FuboTV (NYSE: FUBO) has had a fantastic run from $26.59 to $62 since the start...

Wednesday, December 23, 2020, 10:48:00 AM

Cormark: “Eguana Tech Is At The Very Forefront Of The Growing Wave Of Energy Storage”

Yesterday, Eguana Technologies (TSXV: EGT) released their full year 2020 financial results, alongside an operational...

Friday, January 22, 2021, 11:45:00 AM